Search filters

List of works by Julie Charles

A novel cancer vaccine strategy based on HLA-A*0201 matched allogeneic plasmacytoid dendritic cells

scientific article

Access to molecular guided therapy for Langerhans cell histiocytosis patients.

scientific article

An "anaplastic" Kaposi's sarcoma mimicking a Stewart-Treves syndrome. A case report and a review of literature.

scientific article published on June 2008

Anti-PD1-induced psoriasis: a study of 21 patients

scientific article published on 07 November 2016

BDCA1<sup>+</sup> cDC2s, BDCA2<sup>+</sup> pDCs and BDCA3<sup>+</sup> cDC1s reveal distinct pathophysiologic features and impact on clinical outcomes in melanoma patients

scientific article published on 24 November 2020

Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor

scientific article published on 11 March 2010

Characterization of foreign materials in paraffin-embedded pathological specimens using in situ multi-elemental imaging with laser spectroscopy

scientific article published on 17 November 2017

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses

scientific article published on 18 August 2017

Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes

scientific article published on 09 November 2021

Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy.

scientific article published on 9 February 2018

Fixed drug eruption caused by fulvestrant confirmed by skin tests: First case

scientific article published on 21 November 2018

HLA-A(*)0201(+) plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients.

scientific article

Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms

scientific article published on 08 April 2016

Identification of a novel complex BRAF mutation associated with major clinical response to vemurafenib in a patient with metastatic melanoma

scientific article published in December 2013

Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization.

scientific article published on 21 April 2014

Major response to pembrolizumab in two patients with locally advanced cutaneous squamous cell carcinoma

scientific article published on 19 July 2017

Major response to vemurafenib in patient with severe cutaneous Langerhans cell histiocytosis harboring BRAF V600E mutation.

scientific article published in September 2014

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression.

scientific article published on January 2014

Mesalazine and para-phenylenediamine allergy.

scientific article published in November 2004

Multi-organ failure induced by Nivolumab in the context of allo-stem cell transplantation

scientific article published on 28 March 2019

Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma

article

Nivolumab in previously untreated melanoma without BRAF mutation

scientific article (publication date: 22 January 2015)

Plasma Circulating Tumor DNA Levels for the Monitoring of Melanoma Patients: Landscape of Available Technologies and Clinical Applications.

scientific article published on 6 April 2017

Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

scientific article published on 22 October 2009

Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL.

scientific article published on 26 September 2013

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial

scientific article published on 01 February 2019

The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients

scientific article published on 25 July 2017

Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease

scientific article published on 26 August 2009

[Acantholytic dermatosis in patients treated by vemurafenib: 2 cases].

scientific article published on 23 October 2014

[CDKN2A gene mutation and loss of p16 protein activity in a patient on levodopa presenting sporadic multiple primary melanoma]

scientific article published on 01 October 2006

[Certolizumab]

scientific article published on 14 June 2019

[GENiusVac, a novel antitumor vaccine strategy based on allogeneic plasmacytoid dendritic cells]

scientific article published on 22 March 2011

[Mechanisms of resistance to anti-BRAF treatments].

scientific article published on 7 August 2014

[Reprint of: Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie]

scientific article published on 14 August 2018

[Syringotropic and pilotropic cutaneous T-cell lymphoma without follicular mucinosis]

scientific article published on 01 February 2007

[Treatment of patients with inoperable stage III or stage IV melanoma. Société française de dermatologie]

scientific article published on 25 April 2018